This figure corresponds to the Average Price over the previous 50/200 days.
For DexCom stocks, the 50-day moving average is the support level today.
For DexCom stocks, the 200-day moving average is the support level today.
Are you interested in DexCom, Inc. stocks and want to buy them, or are they already in your portfolio?
If yes, then on this page you will find useful information about the dynamics of the DexCom
stock price in 2024, 2025, 2026, 2027, 2028.
How much will one DexCom share be worth in
2024 - 2028?
When should I take profit in DexCom stock?
When should I record a loss on DexCom stock?
What are analysts' forecasts for DexCom stock?
What is the future of DexCom stock?
We forecast DexCom stock performance using neural networks based on historical data on DexCom stocks.
Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
DexCom stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals.
(Next month, 2024, 2025, 2026, 2027 and 2028)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for DexCom shares. This happens once a day.
Historical and forecast chart of DexCom stock
The chart below shows the historical price of DexCom stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the DexCom stock price can be found in the table below.
Long-term forecasts by years.
Dexcom, Inc. is a medical equipment company. The company is primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for use by people with diabetes and healthcare professionals. Its products include Dexcom G6 and Dexcom stake. The G6 is a CGM system that can be used as part of an integrated system with other compatible medical devices and electronic interfaces, which can include automated insulin dosing systems, insulin pumps, blood glucose meters, or other electronic devices used to treat diabetes. Its Dexcom Share remote monitoring system, offered for use with its Dexcom system, uses an app on a patient’s iPhone, iPod touch, iPad or Android mobile device to securely and wirelessly transfer glucose information to the cloud and then to apps on mobile devices to up to five designated recipients who can remotely monitor patient glucose information and receive alerts.
Trending Themes in the Healthcare Sector
DexCom daily forecast for a month
Date
Target
Pes.
Opt.
Vol., %
Dec 08
120.20
118.79
120.94
1.81
Dec 09
120.67
119.05
122.94
3.26
Dec 10
118.91
117.85
120.68
2.40
Dec 11
117.78
116.66
119.20
2.18
Dec 12
119.40
118.53
120.40
1.58
Dec 13
117.89
116.97
119.81
2.43
Dec 14
116.54
114.84
117.26
2.10
Dec 15
117.39
116.44
118.34
1.64
Dec 16
116.63
115.46
117.42
1.70
Dec 17
115.29
112.78
115.94
2.81
Dec 18
113.49
111.04
116.00
4.46
Dec 19
114.88
112.70
116.14
3.05
Dec 20
116.94
114.59
118.78
3.66
Dec 21
119.96
118.95
120.83
1.58
Dec 22
119.35
116.68
120.35
3.15
Dec 23
119.99
118.47
122.30
3.23
Dec 24
122.64
120.99
124.80
3.15
Dec 25
125.15
124.34
127.18
2.28
Dec 26
124.06
121.28
126.46
4.27
Dec 27
120.66
119.95
121.77
1.52
Dec 28
121.26
120.04
123.20
2.63
Dec 29
120.45
118.83
121.80
2.50
Dec 30
122.81
120.47
125.39
4.08
Dec 31
123.67
122.77
124.67
1.55
Jan 01
127.06
125.18
129.16
3.18
Jan 02
125.89
124.69
128.64
3.17
Jan 03
125.61
123.85
126.80
2.39
Jan 04
124.59
123.86
125.60
1.41
Jan 05
126.02
124.25
127.71
2.78
Jan 06
123.69
122.58
125.04
2.01
DexCom Daily Price Targets
DexCom Stock Forecast 12-08-2023.
Forecast target price for 12-08-2023: $120.20. Positive dynamics for DexCom shares will prevail with possible volatility of 1.781%. Pessimistic target level: 118.79 Optimistic target level: 120.94
DexCom Stock Forecast 12-09-2023.
Forecast target price for 12-09-2023: $120.67. Positive dynamics for DexCom shares will prevail with possible volatility of 3.160%. Pessimistic target level: 119.05 Optimistic target level: 122.94
DexCom Stock Forecast 12-10-2023.
Forecast target price for 12-10-2023: $118.91. Negative dynamics for DexCom shares will prevail with possible volatility of 2.345%. Pessimistic target level: 117.85 Optimistic target level: 120.68
DexCom Stock Forecast 12-11-2023.
Forecast target price for 12-11-2023: $117.78. Negative dynamics for DexCom shares will prevail with possible volatility of 2.130%. Pessimistic target level: 116.66 Optimistic target level: 119.20
DexCom Stock Forecast 12-12-2023.
Forecast target price for 12-12-2023: $119.40. Positive dynamics for DexCom shares will prevail with possible volatility of 1.555%. Pessimistic target level: 118.53 Optimistic target level: 120.40
DexCom Stock Forecast 12-13-2023.
Forecast target price for 12-13-2023: $117.89. Negative dynamics for DexCom shares will prevail with possible volatility of 2.370%. Pessimistic target level: 116.97 Optimistic target level: 119.81
Market capitalization of the DexCom, Inc. is the total market value of all issued shares of a company. It is calculated by the formula
multiplying the number of DXCM shares in the company outstanding by the market price of one share.
EBITDA:
659 600 000 $
EBITDA of DexCom is earnings before interest, income tax and depreciation of assets.
PE Ratio:
128.52
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio:
2.389
Price/earnings to growth
DPS:
N/A
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY:
0.0041
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS:
0.92
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY:
0.187
Quarterly Revenue Growth YOY:
0.267
Trailing PE:
128.52
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE:
68.03
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue:
12.93
Enterprise Value (EV) /Revenue
EV To EBITDA:
55.87
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding:
381674000
Number of issued ordinary shares
Shares Float:
N/A
Number of freely tradable shares
Shares Short Prior Month:
N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and,
moreover, are not trading signals.
When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market
as a result of using the information contained on the site.
This website uses cookies to ensure you get the best experience on our website